Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and scyphostatin

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with scyphostatin in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(scyphostatin)
Trials
(scyphostatin)
Recent Studies (post-2010) (scyphostatin)
9,1561875523806

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)scyphostatin (IC50)
Sphingomyelin phosphodiesterase 2Homo sapiens (human)1
Sphingomyelin phosphodiesterase 2Rattus norvegicus (Norway rat)1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hanada, K; Hara, T; Horii, T; Kurokawa, K; Magistrado, PA; Mitamura, T; Nishijima, M; Palacpac, NM; Rai, G; Sakata, D1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and scyphostatin

ArticleYear
Plasmodium falciparum phospholipase C hydrolyzing sphingomyelin and lysocholinephospholipids is a possible target for malaria chemotherapy.
    The Journal of experimental medicine, 2002, Jan-07, Volume: 195, Issue:1

    Topics: Amides; Amino Acid Sequence; Animals; Genes, Protozoan; Lysophosphatidylcholines; Molecular Sequence Data; Plasmodium falciparum; Platelet Activating Factor; Pyrones; Recombinant Proteins; Sequence Homology, Amino Acid; Sphingomyelin Phosphodiesterase; Sphingomyelins; Substrate Specificity; Type C Phospholipases

2002